Children’s Tylenol Shortage Across Canada
- Manar Zaky
- Dec 15, 2022
- 2 min read
Beginning in the Spring of 2022, an unexpected surge in viral respiratory illnesses initiated a nationwide children’s Tylenol shortage that continues to affect the healthcare system today. As a result, stores and pharmacies are now displaying signage to indicate the lack of availability of children’s pain and fever medication. Given that acetaminophen and ibuprofen are over-the-counter drugs that serve as a quick remedy for various conditions, they are often the first option considered by parents to relieve their child’s symptoms. But what happens when this antidote is no longer easily accessible?
Although Canada is receiving imports of these drugs, an apparent demand-supply imbalance complicates the search for an efficient solution. Moreover, with the increasing infection rates for colds, flu, COVID-19, and respiratory syncytial virus (RSV), incoming shipments of these drugs are not expected to last long. The prevalence of panic buying and the exchange of information on medication sightings among parents heightens this concern. The ongoing shortage has also caused more families to resort to the emergency department, which puts more strain on our already struggling hospitals.
Supply challenges are affected by Canada’s reliance on production in foreign countries due to a limited number of domestic manufacturers. This highlights the problems associated with depending on overseas supply chains, providing a rationale for further exploring domestic options to ensure pharmaceutical security.
Health Canada is presently focused on external sourcing and increasing production efforts within Canada. Companies such as Johnson & Johnson and Haleon have boosted their manufacturing to address the current demand. Assessment procedures accompany these efforts to ensure that these drugs are safe and ready to be distributed equitably to hospitals, pharmacies, and stores. In addition, pharmacies have been encouraged to introduce limits on purchases to provide greater access to individuals or families in need.
Bilingual labelling is also important for Canadian consumers to ensure they can understand critical information about the medicine they are using. This additional requirement may contribute to the slowed circulation of such medications. However, Health Canada has waived some of these regulations on imported drugs to increase drug availability.
Alternatives to children’s liquid cold and flu medication include suppositories or chewable tablets, which could be available when other products are not. In the meantime, health officials urge parents to vaccinate their children and encourage wearing masks. These measures will help protect children and decrease infection rates while we work to address the shortage.
References
https://www.cbc.ca/news/canada/shortage-medication-pain-relief-cold-flu-kids-tylenol-advil-1.6638530
Image from: https://www.cp24.com/polopoly_fs/1.6148987.1668172751!/httpImage/image.jpg_gen/derivatives/landscape_960/image.jpg
Comments